Allogene Therapeutics, Inc.
US ˙ NasdaqGS ˙ US0197701065

Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for Parker Geoffrey M.. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at Parker Geoffrey M. har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:PRGO / Perrigo Company plc Director 9.875
US:ALLO / Allogene Therapeutics, Inc. CHIEF FINANCIAL OFFICER 1.301.540
US:BTTX / Better Therapeutics, Inc. Director 1.031.805
US:CCXI / ChemoCentryx Inc Director 0
US:TCDA / Tricida Inc COO, CFO and EVP 256.000
US:GHDX / Genomic Health, Inc. Director 0
Director 25.000
US:032420AC5 / Anacor Pharmaceuticals Inc. Bond 2.0% 15 OCT 2021 Executive Vice President & CFO 173.000
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af Parker Geoffrey M.. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderkøb ALLO / Allogene Therapeutics, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i ALLO / Allogene Therapeutics, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2024-01-30 ALLO Parker Geoffrey M. 190 3,5950 190 3,5950 683 36 5.6300 387 56,62

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

ALLO / Allogene Therapeutics, Inc. Insider Trades
Insidersalg ALLO / Allogene Therapeutics, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i ALLO / Allogene Therapeutics, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2025-02-03 ALLO Parker Geoffrey M. 4.361 1,7300 4.361 1,7300 7.545 100 0.9528 -3.389 -44,92

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

ALLO / Allogene Therapeutics, Inc. Insider Trades
Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af Parker Geoffrey M. som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2025-08-20 2025-08-18 4/A PRGO PERRIGO Co plc
Ordinary Shares
P - Purchase 4.375 9.875 79,55 22,97 100.497 226.837
2025-08-19 2025-08-18 4 PRGO PERRIGO Co plc
Ordinary Shares
P - Purchase 4.375 33.287 15,13 22,97 100.497 764.629
2025-05-16 2025-05-14 4 PRGO PERRIGO Co plc
Ordinary Shares
F - Taxes -4.754 28.912 -14,12 26,01 -123.652 752.001
2025-05-16 2025-05-14 4 PRGO PERRIGO Co plc
Ordinary Shares
M - Exercise 9.904 33.666 41,68 26,01 257.603 875.653
2025-05-14 2025-05-12 4 PRGO PERRIGO Co plc
Ordinary Shares
P - Purchase 3.500 23.762 17,27 27,10 94.850 643.950
2025-02-05 2025-02-03 4 ALLO Allogene Therapeutics, Inc.
Common Stock
S - Sale -4.361 1.301.540 -0,33 1,73 -7.545 2.251.664
2025-01-28 2025-01-24 4 ALLO Allogene Therapeutics, Inc.
Common Stock
A - Award 173.913 1.305.901 15,36
2024-10-23 2024-10-21 4 ALLO Allogene Therapeutics, Inc.
Common Stock
F - Taxes -36.404 1.131.988 -3,12 2,84 -103.387 3.214.846
2024-05-20 2024-05-16 4 ALLO Allogene Therapeutics, Inc.
Common Stock
A - Award 344.828 1.164.418 42,07 2,90 1.000.001 3.376.812
2024-05-16 2024-05-15 4 PRGO PERRIGO Co plc
Ordinary Shares
F - Taxes -4.207 20.262 -17,19 30,22 -127.136 612.318
2024-05-16 2024-05-15 4 PRGO PERRIGO Co plc
Ordinary Shares
M - Exercise 8.764 24.469 55,80 30,22 264.848 739.453
2024-03-06 2024-01-30 4 ALLO Allogene Therapeutics, Inc.
Common Stock
P - Purchase 190 819.590 0,02 3,60 683 2.946.426
2024-01-31 2024-01-25 4 ALLO Allogene Therapeutics, Inc.
Common Stock
A - Award 29.400 819.400 3,72
2023-12-20 2023-12-18 4 BTTX Better Therapeutics, Inc.
Common Stock
A - Award 3.750 1.031.805 0,36
2023-10-17 2023-10-16 4 ALLO Allogene Therapeutics, Inc.
Common Stock
A - Award 390.000 790.000 97,50
2023-10-17 2023-10-16 4 ALLO Allogene Therapeutics, Inc.
Common Stock
A - Award 400.000 400.000
2023-07-31 2023-07-27 4 BTTX Better Therapeutics, Inc.
Common Stock
P - Purchase 685.025 1.028.055 199,70 0,73 500.000 750.377
2023-06-14 2023-06-13 4 PRGO PERRIGO Co plc
Ordinary Shares
P - Purchase 10.000 25.879 62,98 33,06 330.637 855.655
2023-05-19 2023-05-17 4 PRGO PERRIGO Co plc
Ordinary Shares
F - Taxes -3.734 15.705 -19,21 32,86 -122.699 516.066
2023-05-19 2023-05-17 4 PRGO PERRIGO Co plc
Ordinary Shares
M - Exercise 7.778 19.439 66,70 32,86 255.585 638.766
2023-04-12 2023-04-10 4 BTTX Better Therapeutics, Inc.
Common Stock
P - Purchase 303.030 343.030 757,58 0,82 250.000 283.000
2023-03-07 2023-03-06 4 PRGO PERRIGO Co plc
Ordinary Shares
P - Purchase 5.000 15.879 45,96 38,05 190.270 604.259
2022-10-24 2022-10-20 4 CCXI ChemoCentryx, Inc.
Common Stock
D - Sale to Issuer -5.000 0 -100,00
2022-10-24 2022-10-20 4 CCXI ChemoCentryx, Inc.
Common Stock
D - Sale to Issuer -21.076 0 -100,00
2022-10-24 2022-10-20 4 CCXI ChemoCentryx, Inc.
Common Stock
D - Sale to Issuer -107.997 0 -100,00
2022-06-14 2022-06-13 4 BTTX Better Therapeutics, Inc.
Common Stock
P - Purchase 25.000 40.000 166,67 1,45 36.182 57.892
2022-05-24 2022-05-20 4 CCXI ChemoCentryx, Inc.
Restricted Stock Units
M - Exercise -7.726 0 -100,00
2022-05-24 2022-05-20 4 CCXI ChemoCentryx, Inc.
Common Stock
M - Exercise 7.726 21.076 57,87
2022-05-19 2022-05-17 4 PRGO PERRIGO Co plc
Restricted Stock Units
M - Exercise -6.599 0 -100,00
2022-05-19 2022-05-17 4 PRGO PERRIGO Co plc
Restricted Stock Units
A - Award 7.778 7.778
2022-05-19 2022-05-17 4 PRGO PERRIGO Co plc
Ordinary Shares
F - Taxes -3.168 11.661 -21,36 38,57 -122.190 449.765
2022-05-19 2022-05-17 4 PRGO PERRIGO Co plc
Ordinary Shares
M - Exercise 6.599 14.829 80,18 38,57 254.523 571.955
2022-05-03 2022-05-02 4 CCXI ChemoCentryx, Inc.
Stock Option (right to buy)
M - Exercise -12.500 0 -100,00
2022-05-03 2022-05-02 4 CCXI ChemoCentryx, Inc.
Common Stock
M - Exercise 12.500 124.413 11,17 14,42 180.250 1.794.035
2022-03-31 2022-03-29 4 BTTX Better Therapeutics, Inc.
Common Stock
P - Purchase 15.000 15.000 2,15 32.230 32.230
2022-03-02 2022-02-28 4 TCDA Tricida, Inc.
Employee Stock Option (right to buy)
A - Award 256.000 256.000
2022-01-04 2021-12-31 4 TCDA Tricida, Inc.
Common Stock
F - Taxes -1.384 63.617 -2,13 9,56 -13.231 608.179
2021-12-17 2021-12-16 4 PRGO PERRIGO Co plc
Ordinary Shares
P - Purchase 5.000 10.879 85,05 36,85 184.270 400.935
2021-12-16 2021-12-14 4 BTTX Better Therapeutics, Inc.
Common Stock
P - Purchase 20.000 53.333 60,00 4,94 98.800 263.465
2021-11-17 2021-11-15 4 TCDA Tricida, Inc.
Common Warrants
A - Award 166.667 166.667
2021-11-17 2021-11-15 4 TCDA Tricida, Inc.
Common Stock
A - Award 166.667 261.667 175,44 6,00 1.000.002 1.570.002
2021-11-01 2021-10-28 4 BTTX Better Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 28.300 28.300
2021-11-01 2021-10-28 4 BTTX Better Therapeutics, Inc.
Common Stock
A - Award 33.333 33.333
2021-11-01 3 BTTX Better Therapeutics, Inc.
Common Stock
33.333
2021-05-24 2021-05-21 4 CCXI ChemoCentryx, Inc.
Restricted Stock Units
M - Exercise -4.660 0 -100,00
2021-05-24 2021-05-21 4 CCXI ChemoCentryx, Inc.
Common Stock
M - Exercise 4.660 13.350 53,62
2021-05-24 2021-05-20 4 CCXI ChemoCentryx, Inc.
Stock Option (right to buy)
A - Award 4.504 4.504
2021-05-24 2021-05-20 4 CCXI ChemoCentryx, Inc.
Restricted Stock Units
A - Award 7.726 7.726
2021-05-24 2021-03-10 4 CCXI ChemoCentryx, Inc.
Common Stock
G - Gift -4.000 8.690 -31,52
2021-05-19 2021-05-17 4 PRGO PERRIGO Co plc
Restricted Stock Units
A - Award 6.599 6.599
2021-05-11 2021-05-07 4 PRGO PERRIGO Co plc
Restricted Stock Units
M - Exercise -5.804 0 -100,00
2021-05-11 2021-05-07 4 PRGO PERRIGO Co plc
Ordinary Shares
F - Taxes -2.786 11.459 -19,56 42,96 -119.687 492.279
2021-05-11 2021-05-07 4 PRGO PERRIGO Co plc
Ordinary Shares
M - Exercise 5.804 14.245 68,76 42,96 249.340 611.965
2021-03-18 2021-03-17 4 PRGO PERRIGO Co plc
Ordinary Shares
P - Purchase 2.500 2.650 1.666,67 41,29 103.218 109.411
2021-03-08 2021-03-05 4 CCXI ChemoCentryx, Inc.
Common Stock
S - Sale -13.330 12.690 -51,23 55,89 -744.974 709.206
2021-03-08 2021-03-05 4 CCXI ChemoCentryx, Inc.
Common Stock
S - Sale -16.670 26.020 -39,05 56,78 -946.494 1.477.371
2021-03-08 2021-03-04 4 CCXI ChemoCentryx, Inc.
Common Stock
S - Sale -1.910 42.690 -4,28 60,20 -114.980 2.569.904
2021-02-04 2020-06-15 5 CCXI ChemoCentryx, Inc.
Common Stock
G - Gift -5.000 44.600 -10,08
2021-01-20 2021-01-17 4 TCDA Tricida, Inc.
Employee Stock Option (right to buy)
A - Award 216.000 216.000
2020-12-10 2020-12-10 4 TCDA Tricida, Inc.
Common Stock
P - Purchase 15.000 40.000 60,00 6,78 101.700 271.200
2020-09-14 2020-09-10 4 TCDA Tricida, Inc.
Common Stock
A - Award 4.000 60.837 7,04
2020-05-26 2020-05-23 4 CCXI ChemoCentryx, Inc.
Restricted Stock Units
M - Exercise -7.724 0 -100,00
2020-05-26 2020-05-23 4 CCXI ChemoCentryx, Inc.
Common Stock
M - Exercise 7.724 111.913 7,41
2020-05-26 2020-05-21 4 CCXI ChemoCentryx, Inc.
Restricted Stock Units
A - Award 4.660 4.660
2020-05-26 2020-05-21 4 CCXI ChemoCentryx, Inc.
Stock Option (right to buy)
A - Award 2.888 2.888
2020-05-19 2020-05-15 4 PRGO PERRIGO Co plc
Restricted Stock Units
M - Exercise -6.054 0 -100,00
2020-05-19 2020-05-15 4 PRGO PERRIGO Co plc
Ordinary Shares
F - Taxes -2.906 8.441 -25,61 52,76 -153.321 445.347
2020-05-19 2020-05-15 4 PRGO PERRIGO Co plc
Ordinary Shares
M - Exercise 6.054 11.347 114,38 52,76 319.409 598.668
2020-05-12 2020-05-12 4 TCDA Tricida, Inc.
Common Stock
P - Purchase 1.439 95.000 1,54 31,66 45.559 3.007.700
2020-05-12 2020-05-12 4 TCDA Tricida, Inc.
Common Stock
P - Purchase 1.303 93.561 1,41 30,09 39.207 2.815.250
2020-05-12 2020-05-11 4 TCDA Tricida, Inc.
Common Stock
P - Purchase 19.854 92.258 27,42 30,36 602.767 2.800.953
2020-05-12 2020-05-11 4 TCDA Tricida, Inc.
Common Stock
P - Purchase 12.404 72.404 20,67 29,48 365.670 2.134.470
2020-05-11 2020-05-07 4 PRGO PERRIGO Co plc
Restricted Stock Units
A - Award 5.804 5.804
2020-03-25 2020-03-23 4 CCXI ChemoCentryx, Inc.
Common Stock
S - Sale -860 49.600 -1,70 38,21 -32.863 1.895.355
2020-03-25 2020-03-23 4 CCXI ChemoCentryx, Inc.
Common Stock
S - Sale -13.959 50.460 -21,67 37,40 -522.008 1.886.992
2020-03-25 2020-03-23 4 CCXI ChemoCentryx, Inc.
Common Stock
S - Sale -9.181 64.419 -12,47 36,72 -337.100 2.365.279
2020-03-25 2020-03-23 4 CCXI ChemoCentryx, Inc.
Common Stock
S - Sale -2.801 73.600 -3,67 35,32 -98.932 2.599.559
2020-03-25 2020-03-23 4 CCXI ChemoCentryx, Inc.
Common Stock
S - Sale -3.199 76.401 -4,02 34,43 -110.147 2.630.609
2020-03-11 2020-03-10 4 TCDA Tricida, Inc.
Common Stock
P - Purchase 5.000 55.000 10,00 29,46 147.300 1.620.300
2020-02-26 2020-02-24 4 TCDA Tricida, Inc.
Employee Stock Option (right to buy)
A - Award 130.000 130.000
2020-02-05 2019-12-10 5 CCXI ChemoCentryx, Inc.
Common Stock
G - Gift -20.000 79.600 -20,08
2019-12-04 2019-12-02 4 CCXI ChemoCentryx, Inc.
Stock Option (right to buy)
M - Exercise -31.990 0 -100,00
2019-12-04 2019-12-02 4 CCXI ChemoCentryx, Inc.
Common Stock
M - Exercise 31.990 104.189 44,31 6,00 191.940 625.134
2019-11-19 2019-11-19 4 TCDA Tricida, Inc.
Common Stock
P - Purchase 945 50.000 1,93 34,72 32.810 1.736.000
2019-11-19 2019-11-18 4 TCDA Tricida, Inc.
Common Stock
P - Purchase 19.055 49.055 63,52 34,28 653.205 1.681.605
2019-11-14 2019-11-08 4 GHDX GENOMIC HEALTH INC
Director Stock Option (right to buy)
D - Sale to Issuer -6.583 0 -100,00
2019-11-14 2019-11-08 4 GHDX GENOMIC HEALTH INC
Director Stock Option (right to buy)
D - Sale to Issuer -10.000 0 -100,00
2019-11-14 2019-11-08 4 GHDX GENOMIC HEALTH INC
Director Stock Option (right to buy)
D - Sale to Issuer -10.000 0 -100,00
2019-11-14 2019-11-08 4 GHDX GENOMIC HEALTH INC
Director Stock Option (right to buy)
D - Sale to Issuer -20.000 0 -100,00
2019-11-14 2019-11-08 4 GHDX GENOMIC HEALTH INC
Common Stock
A - Award -955 0 -100,00
2019-09-04 2019-09-03 4 TCDA Tricida, Inc.
Employee Stock Option (right to buy)
M - Exercise -54.347 196.909 -21,63
2019-09-04 2019-09-03 4 TCDA Tricida, Inc.
Common Stock
M - Exercise 54.347 56.122 3.061,80 1,84 99.998 103.264
2019-08-23 2019-08-22 4 TCDA Tricida, Inc.
Employee Stock Option (right to buy)
A - Award 30.000 30.000
2019-08-14 2019-08-13 4 TCDA Tricida, Inc.
Common Stock
P - Purchase 4.531 30.000 17,79 33,60 152.242 1.008.000
2019-08-14 2019-08-13 4 TCDA Tricida, Inc.
Common Stock
P - Purchase 7.416 25.469 41,08 32,91 244.061 838.185
2019-08-14 2019-08-12 4 TCDA Tricida, Inc.
Common Stock
P - Purchase 2.577 18.053 16,65 32,56 83.907 587.806
2019-08-14 2019-08-12 4 TCDA Tricida, Inc.
Common Stock
P - Purchase 15.476 15.476 31,64 489.661 489.661
2019-06-18 2019-06-14 4 GHDX GENOMIC HEALTH INC
Director Stock Option (right to buy)
A - Award 6.583 6.583
2019-06-18 2019-06-14 4 GHDX GENOMIC HEALTH INC
Common Stock
A - Award 955 955
2019-06-03 2019-05-30 4 CCXI ChemoCentryx, Inc.
Stock Option (right to buy)
M - Exercise -18.010 31.990 -36,02
2019-06-03 2019-05-30 4 CCXI ChemoCentryx, Inc.
Common Stock
S - Sale -12.815 72.199 -15,07 12,00 -153.806 866.532
2019-06-03 2019-05-30 4 CCXI ChemoCentryx, Inc.
Common Stock
M - Exercise 18.010 85.014 26,88 6,00 108.060 510.084
2019-05-23 2019-05-23 4 CCXI ChemoCentryx, Inc.
Stock Option (right to buy)
A - Award 12.287 12.287
2019-05-23 2019-05-23 4 CCXI ChemoCentryx, Inc.
Restricted Stock Units
A - Award 7.724 7.724
2019-05-23 2019-05-21 4 CCXI ChemoCentryx, Inc.
Restricted Stock Units
M - Exercise -8.421 0 -100,00
2019-05-23 2019-05-21 4 CCXI ChemoCentryx, Inc.
Common Stock
M - Exercise 8.421 67.004 14,37
2019-05-17 2019-05-15 4 PRGO PERRIGO Co plc
Restricted Stock Units
M - Exercise -3.971 0 -100,00
2019-05-17 2019-05-15 4 PRGO PERRIGO Co plc
Restricted Stock Units
A - Award 6.054 6.054
2019-05-17 2019-05-15 4 PRGO PERRIGO Co plc
Ordinary Shares
F - Taxes -1.907 5.293 -26,49 49,55 -94.492 262.268
2019-05-17 2019-05-15 4 PRGO PERRIGO Co plc
Ordinary Shares
M - Exercise 3.971 7.200 122,98 49,55 196.763 356.760
2019-04-08 2019-04-04 4 TCDA Tricida, Inc.
Common Stock
A - Award 20.000 25.000 400,00 36,00 720.000 900.000
2019-02-22 2019-02-20 4 TCDA Tricida, Inc.
Employee Stock Option (right to buy)
A - Award 100.000 100.000
2018-11-13 2018-11-12 4 PRGO PERRIGO Co plc
Ordinary Shares
P - Purchase 3.000 5.500 120,00 65,35 196.058 359.440
2018-11-13 2018-11-13 4 TCDA Tricida, Inc.
Common Stock
P - Purchase 5.000 65.000 8,33 29,72 148.600 1.931.800
2018-07-02 2018-07-02 4 TCDA Tricida, Inc.
Common Stock
P - Purchase 60.000 60.000 19,00 1.140.000 1.140.000
2018-06-11 2018-06-07 4 GHDX GENOMIC HEALTH INC
Director Stock Option (right to buy)
A - Award 10.000 10.000
2018-06-08 2018-06-06 4 PRGO PERRIGO Co plc
Restricted Stock Units
M - Exercise 4.265 0 -100,00
2018-06-08 2018-06-06 4 PRGO PERRIGO Co plc
Ordinary Shares
F - Taxes -2.048 3.229 -38,81 73,22 -149.955 236.427
2018-06-08 2018-06-06 4 PRGO PERRIGO Co plc
Ordinary Shares
M - Exercise 4.265 5.277 421,44 73,22 312.283 386.382
2018-05-30 2018-05-25 4 CCXI ChemoCentryx, Inc.
Restricted Stock Units
M - Exercise -12.912 0 -100,00
2018-05-30 2018-05-25 4 CCXI ChemoCentryx, Inc.
Common Stock
M - Exercise 12.912 58.583 28,27
2018-05-23 2018-05-21 4 CCXI ChemoCentryx, Inc.
Stock Option (Right to buy)
A - Award 13.352 13.352
2018-05-23 2018-05-21 4 CCXI ChemoCentryx, Inc.
Restricted Stock Units
A - Award 8.421 8.421
2018-05-17 2018-05-15 4 PRGO PERRIGO Co plc
Restricted Stock Units
A - Award 3.971 3.971
2017-07-24 2017-07-20 4 PRGO PERRIGO Co plc
Restricted Stock Units
M - Exercise -511 0 -100,00
2017-07-24 2017-07-20 4 PRGO PERRIGO Co plc
Restricted Stock Units
M - Exercise -1.437 0 -100,00
2017-07-24 2017-07-20 4 PRGO PERRIGO Co plc
Ordinary Shares
F - Taxes -246 1.012 -19,55 75,51 -18.575 76.416
2017-07-24 2017-07-20 4 PRGO PERRIGO Co plc
Ordinary Shares
M - Exercise 511 1.258 68,41 75,51 38.586 94.992
2017-07-24 2017-07-20 4 PRGO PERRIGO Co plc
Ordinary Shares
F - Taxes -690 747 -48,02 75,51 -52.102 56.406
2017-07-24 2017-07-20 4 PRGO PERRIGO Co plc
Ordinary Shares
M - Exercise 1.437 1.437 75,51 108.508 108.508
2017-06-20 2017-06-16 4 GHDX GENOMIC HEALTH INC
Director Stock Option (right to buy)
A - Award 10.000 10.000
2017-06-08 2017-06-06 4 PRGO PERRIGO Co plc
Restricted Stock Units
A - Award 1.437 1.437
2017-06-08 2017-06-06 4 PRGO PERRIGO Co plc
Restricted Stock Units
A - Award 4.265 4.265
2017-06-02 2017-05-31 4 SNSS SUNESIS PHARMACEUTICALS INC
Stock Option (Right to Buy)
A - Award 25.000 25.000
2017-05-30 2017-05-26 4 CCXI ChemoCentryx, Inc.
Restricted Stock Units
M - Exercise -20.362 0 -100,00
2017-05-30 2017-05-26 4 CCXI ChemoCentryx, Inc.
Common Stock
M - Exercise 20.362 45.671 80,45
2017-05-30 2017-05-25 4 CCXI ChemoCentryx, Inc.
Restricted Stock Units
A - Award 12.912 12.912
2017-05-03 2016-11-17 4/A PRGO PERRIGO Co plc
Restricted Stock Units
A - Award 511 511
2016-12-16 2016-12-09 4/A SNSS SUNESIS PHARMACEUTICALS INC
Common Stock
P - Purchase 594 14.074 4,41 3,90 2.318 54.914
2016-12-16 2016-12-08 4/A SNSS SUNESIS PHARMACEUTICALS INC
Common Stock
P - Purchase 3.146 13.480 30,44 3,86 12.159 52.100
2016-12-12 2016-12-09 4 SNSS SUNESIS PHARMACEUTICALS INC
Common Stock
P - Purchase 594 65.745 0,91 3,90 2.318 256.524
2016-12-12 2016-12-08 4 SNSS SUNESIS PHARMACEUTICALS INC
Common Stock
P - Purchase 3.146 65.151 5,07 3,86 12.159 251.809
2016-11-21 2016-11-21 4 PRGO PERRIGO Co plc
Ordinary Shares
P - Purchase 2.500 2.500 88,75 221.875 221.875
2016-11-18 2016-11-17 4 PRGO PERRIGO Co plc
Restricted Stock Units
A - Award 511 511
2016-11-14 3 PRGO PERRIGO Co plc
Ordinary Shares
300
2016-11-14 3 PRGO PERRIGO Co plc
Ordinary Shares
300
2016-06-23 2016-06-21 4 GHDX GENOMIC HEALTH INC
Director Stock Option (right to buy)
A - Award 20.000 20.000
2016-05-27 2016-05-26 4 CCXI ChemoCentryx, Inc.
Restricted Stock Units
A - Award 20.362 20.362
2016-05-27 2016-05-26 4 SNSS SUNESIS PHARMACEUTICALS INC
Common Stock
P - Purchase 9.500 62.005 18,09 0,47 4.455 29.074
2016-05-26 2016-05-25 4 SNSS SUNESIS PHARMACEUTICALS INC
Common Stock
P - Purchase 22.505 52.505 75,02 0,49 10.933 25.507
2016-05-26 2016-05-24 4 SNSS SUNESIS PHARMACEUTICALS INC
Common Stock
P - Purchase 30.000 30.000 0,46 13.881 13.881
2016-05-24 2016-05-21 4 CCXI ChemoCentryx, Inc.
Restricted Stock Units
M - Exercise -11.795 0 -100,00
2016-05-24 2016-05-21 4 CCXI ChemoCentryx, Inc.
Common Stock
M - Exercise 11.795 25.309 87,28
2016-05-13 2016-05-13 4 CCXI ChemoCentryx, Inc.
Common Stock
P - Purchase 40.000 99.600 67,11 4,03 161.388 401.856
2016-04-01 2016-03-31 4 SNSS SUNESIS PHARMACEUTICALS INC
Stock Option (Right to Buy)
A - Award 75.000 75.000
2016-01-11 2016-01-11 4 CCXI ChemoCentryx, Inc.
Common Stock
P - Purchase 20.000 59.600 50,51 4,63 92.512 275.686
2015-12-14 2015-12-11 4 CCXI ChemoCentryx, Inc.
Common Stock
P - Purchase 4.621 39.600 13,21 7,30 33.724 289.001
2015-12-14 2015-12-10 4 CCXI ChemoCentryx, Inc.
Common Stock
P - Purchase 15.379 34.979 78,46 7,23 111.202 252.926
2015-05-29 2015-05-27 4 CCXI ChemoCentryx, Inc.
Common Stock
S - Sale X -13.513 13.514 -50,00 7,51 -101.515 101.523
2015-05-26 2015-05-22 4 CCXI ChemoCentryx, Inc.
Restricted Stock Units
M - Exercise -27.027 0 -100,00
2015-05-26 2015-05-22 4 CCXI ChemoCentryx, Inc.
Common Stock
M - Exercise 27.027 27.027
2015-05-26 2015-05-21 4 CCXI ChemoCentryx, Inc.
Restricted Stock Units
A - Award 11.795 11.795
2015-03-23 2015-03-23 4 ANAC Anacor Pharmaceuticals, Inc.
Common Stock
P - Purchase 3.000 173.000 1,76 52,43 157.304 9.071.186
2015-02-05 2015-02-03 4 ANAC Anacor Pharmaceuticals, Inc.
Performance Restricted Stock Units
A - Award 6.930 6.930
2015-02-05 2015-02-03 4 ANAC Anacor Pharmaceuticals, Inc.
Stock Option (right to buy)
A - Award 28.400 28.400
2015-02-05 2015-02-03 4 ANAC Anacor Pharmaceuticals, Inc.
Common Stock
A - Award 6.840 94.840 7,77
2014-09-08 2014-09-08 4 ANAC Anacor Pharmaceuticals, Inc.
Common Stock
P - Purchase 1.229 170.000 0,73 22,05 27.095 3.747.939
2014-09-08 2014-09-05 4 ANAC Anacor Pharmaceuticals, Inc.
Common Stock
P - Purchase 5.361 168.771 3,28 21,77 116.712 3.674.229
2014-05-30 2014-05-29 4 ANAC Anacor Pharmaceuticals, Inc.
Stock Option (right to buy)
A - Award 40.000 40.000
2014-05-23 2014-05-22 4 CCXI ChemoCentryx, Inc.
Restricted Stock Units
A - Award 27.027 27.027
2014-03-24 2014-03-24 4 ANAC Anacor Pharmaceuticals, Inc.
Common Stock
P - Purchase 5.000 163.410 3,16 20,11 100.533 3.285.620
2014-03-19 2014-03-18 4 ANAC Anacor Pharmaceuticals, Inc.
Common Stock
P - Purchase 2.410 158.410 1,54 22,60 54.469 3.580.288
2014-02-10 2014-02-07 4 ANAC Anacor Pharmaceuticals, Inc.
Stock Option (right to buy)
A - Award 54.000 54.000
2013-12-09 2013-12-06 4 CCXI ChemoCentryx, Inc.
Common Stock
P - Purchase 15.000 15.000 5,15 77.265 77.265
2013-12-09 2013-12-06 4 CCXI ChemoCentryx, Inc.
Common Stock
P - Purchase 5.000 9.600 108,70 5,15 25.757 49.453
2013-11-27 2013-11-26 4 ANAC Anacor Pharmaceuticals, Inc.
Common Stock
P - Purchase 10.000 156.000 6,85 13,40 133.950 2.089.620
2013-11-26 2013-11-25 4 ANAC Anacor Pharmaceuticals, Inc.
Common Stock
P - Purchase 10.000 146.000 7,35 12,85 128.475 1.875.735
2013-10-04 2013-10-04 4 ANAC Anacor Pharmaceuticals, Inc.
Stock Option (right to buy)
X - Other -80.000 101.579 -44,06 5,00 -400.000 507.895
2013-10-04 2013-10-04 4 ANAC Anacor Pharmaceuticals, Inc.
Common Stock
X - Other 80.000 85.000 1.600,00 5,00 400.000 425.000
2013-08-13 2013-08-13 4 ANAC Anacor Pharmaceuticals, Inc.
Common Stock
P - Purchase 50.000 136.000 58,14 8,34 417.205 1.134.798
2013-06-19 2013-06-19 4 ANAC Anacor Pharmaceuticals, Inc.
Common Stock
P - Purchase 23.046 86.000 36,61 5,20 119.948 447.604
2013-06-18 2013-06-18 4 ANAC Anacor Pharmaceuticals, Inc.
Common Stock
P - Purchase 10.000 62.954 18,88 5,22 52.193 328.576
2013-06-18 2013-06-18 4 ANAC Anacor Pharmaceuticals, Inc.
Common Stock
P - Purchase 10.000 10.000 5,22 52.180 52.180
2013-05-28 2013-05-23 4 CCXI ChemoCentryx, Inc.
Stock Option (right to buy)
A - Award 12.500 12.500
2013-04-16 2013-04-12 4 ANAC Anacor Pharmaceuticals, Inc.
Stock Option (right to buy)
A - Award 120.000 120.000
2012-08-24 2012-08-22 4 ANAC Anacor Pharmaceuticals Inc
Common Stock
P - Purchase 5.000 55.954 9,81 6,19 30.956 346.417
2012-06-26 2012-06-22 4 CCXI ChemoCentryx, Inc.
Stock Option (right to buy)
A - Award 12.500 12.500
2012-06-05 2012-06-05 4 ANAC Anacor Pharmaceuticals Inc
Common Stock
P - Purchase 4.314 49.954 9,45 4,93 21.259 246.173
2012-06-05 2012-06-04 4 ANAC Anacor Pharmaceuticals Inc
Common Stock
P - Purchase 3.640 45.640 8,67 4,68 17.035 213.595
2012-03-20 2012-03-20 4 ANAC Anacor Pharmaceuticals Inc
Common Stock
P - Purchase 9.400 42.000 28,83 6,08 57.196 255.557
2012-03-20 2012-03-19 4 ANAC Anacor Pharmaceuticals Inc
Common Stock
P - Purchase 600 32.600 1,88 6,03 3.618 196.578
2012-03-14 2012-03-13 4 ANAC Anacor Pharmaceuticals Inc
Stock Option (right to buy)
A - Award 55.000 55.000
2012-02-13 2012-02-10 4 CCXI ChemoCentryx, Inc.
Common Stock
P - Purchase 4.600 4.600 10,97 50.462 50.462
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)